TCF

Welcome to the Brand page for “TCF”, which is offered here for Pharmaceutical [ and veterinary ] preparations for the treatment of cancer, including hematologic cancers, [ viral mediated diseases, bacterial mediated diseases, and inflammatory and autoimmune diseases, including rheumatoid arthritis, osteoarthritis, crohn's disease, psoriasis, psoriatic arthritis, ], polypeptides and proteins made by genetic engineering, including fusion proteins, cells, body cells and cells of the immune system of mammals, including human cells [ ; diagnostic preparations for medical purposes ];[ chemical preparations for industrial and scientific use, polypeptides and proteins made by genetic engineering, including fusion proteins as well as nucleic acids encoding these polypeptides and proteins, body cells and cells of the immune system of mammals, including human cells; analytical kits consisting of chemical reagents for industrial and scientific use, for the purification, detection and immobilization of fusion proteins, fusion peptides and cells, body cells and cells of the immune system of mammals, including human cells; diagnostic preparations except for medical purposes ];[ scientific and industrial research in the field of biochemistry, diagnostics and pharmaceutics; biochemical or pharmaceutical laboratory services, synthesis of recombinant polypeptides and proteins, cultivation and purification of cells, of body cells and cells of the immune system of mammals including human cells ];.

Its status is currently believed to be active. Its class is unavailable. “TCF” is believed to be currently owned by “Kite Pharma EU B.V.”